Evidence map›Paper›PMID 38867867›Full record

ArticleEuropean heart journal supplements : journal of the European Society of Cardiology2024

The point on the treatment of arrhythmic storm.

Ludovico Lazzari, Stefano Donzelli, Alessandra Tordini, Antonio Parise, Ciro Pirozzi, Federica Di Meo, Carmine Marallo, Vincenzo Pace, Chiara Marini, Giovanni Carreras

Abstract read
In one paragraph

Article in European heart journal supplements : journal of the European Society of Cardiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ludovico LazzariSSD of Clinical and Interventional Arrhythmology, 'S. Maria', Terni.
Stefano DonzelliSSD of Clinical and Interventional Arrhythmology, 'S. Maria', Terni.
Alessandra TordiniSSD of Clinical and Interventional Arrhythmology, 'S. Maria', Terni.
Antonio PariseSSD of Clinical and Interventional Arrhythmology, 'S. Maria', Terni.
Ciro PirozziCardiology Unit, 'S. Maria della Pietà', Nola.
Federica Di MeoSSD of Clinical and Interventional Arrhythmology, 'S. Maria', Terni.
Carmine MaralloDepartment of Medical Biotechnology, University of Siena.
Vincenzo PaceSSD of Clinical and Interventional Arrhythmology, 'S. Maria', Terni.
Chiara MariniSC of Cardiology, 'S. Maria', Terni.
Giovanni CarrerasSSD of Clinical and Interventional Arrhythmology, 'S. Maria', Terni.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Arrhythmic storm is a clinical emergency associated with high mortality, which requires multi-disciplinary management. Reprogramming of the implantable cardiac defibrillator (ICD) aimed at reducing shocks, adrenergic blockade using beta-blockers, sedation/anxiolysis, and blockade of the stellate ganglion represent the first simple and effective manoeuvres, but further suppression of arrhythmias with antiarrhythmics is often required. A low-risk patient (e.g. monomorphic ventricular tachycardia, functioning ICD, and haemodynamically stable) should be managed with a beta-blocker (possibly non-selective) plus amiodarone, in addition to sedation with a benzodiazepine or dexmedetomidine; in patients at greater risk (high burden and haemodynamic instability), autonomic modulation with blockade of the stellate ganglion and the addition of a second antiarrhythmic (lidocaine) should be considered. In patients refractory to these measures, with advanced heart failure, general anaesthesia with intubation and the establishment of a haemodynamic circulatory support should be considered. Ablation, performed early, appears to be superior in terms of mortality and reduction of future shocks compared with titration of antiarrhythmics.

Indexed as

Arrhythmic stormImplantable cardiac defibrillatorTranscatheter ablation

Identifiers

PMID38867867
PMCPMC11167961

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.